首页 | 本学科首页   官方微博 | 高级检索  
     


The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework
Authors:Moltzan C J  Anderson D A  Callum J  Fremes S  Hume H  Mazer C D  Poon M C  Rivard G  Rizoli S  Robinson S
Affiliation:Department of Internal Medicine, St. Boniface General Hospital, Winnipeg; , Department of Internal Medicine, QEII Health Sciences Centre, Halifax; , Department of Pathology and Laboratory Medicine, Sunnybrook Health Sciences Centre, Toronto; , Department of Surgery, Sunnybrook Health Sciences Centre, Toronto; , Transfusion Medicine, Canadian Blood Services Head Office, Ottawa; , Departments of Physiology, Anesthesia and Critical Care, St. Michael's Hospital, Toronto; , Department of Medicine, Foothills Hospital, Calgary; , Department of Pediatrics, Sainte-Justine Hospital, Montreal; , and Departments of Surgery and Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto
Abstract:summary .  A review of the recent randomized control trial evidence of the use of recombinant factor VIIa (rFVIIa) in massive bleeding. rFVIIa is a recombinant genetically engineered clotting factor that has been used for the management of haemophilia patients with inhibitors. There has been increasing use in patients with massive bleeding, even when there is no underlying coagulation disorder present. In November 2006, the Canadian National Advisory Committee on Blood and Blood Products engaged in a consultation and review process with several leading Canadian experts to review and discuss the current evidence up to November 2006. There is little evidence to support the routine use of rFVIIa in massive bleeding on review of 13 randomized controlled trials. rFVIIa should only be considered as part of a transfusion policy framework for massive bleeding after all other transfusion and supportive measures are considered. An example of a policy framework is presented.
Keywords:massive bleeding (haemorrhage)    transfusion protocol    recombinant activated factor VII
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号